The balance between interleukin-18 (IL-18) and its endogenous antagonist, IL-18 binding protein (IL-18BP), was evaluated in children with Henoch-Schönlein purpura (HSP). Plasma IL-18 and IL-18BP levels and peripheral blood mononuclear cell IL-18 mRNA expression were significantly higher in patients with active HSP (n = 30) than in healthy controls (n = 20); IL-18BP mRNA expression was similar in active HSP and controls. Plasma levels and mRNA expression of IL-18 and IL-18BP in patients in remission (n = 19) were similar to those in controls. The ratios of IL-18 / IL-18BP plasma levels and IL-18 / IL-18BP mRNA levels in active HSP were significantly higher than in patients in remission and healthy controls. Thus, adequate IL-18BP to block the proinflammatory activity of IL-18 may not be present in active HSP and regulation of the IL-18 / IL-18BP balance might provide a potential therapeutic strategy.
DingWSunSZhenJ: Urinary excretion and renal production of hepatocyte growth factor in children with Henoch-Schönlein purpura. J Int Med Res2010; 38: 1933–1941.
3.
Spasojević-DimitrijevaBKostićMPeco-AntićA: Henoch-Schönlein purpura outcome in children: A ten-year clinical study. Srp Arh Celok Lek2011; 139: 174–178.
4.
VatsKRVatsAKimY: Henoch-Schönlein purpura and pulmonary hemorrhage: A report and literature review. Pediatr Nephrol1999; 13: 530–534.
FlatauEKohnDSchillerD: Schönlein-Henoch purpura in patients with familial Mediterranean fever. Arthritis Rheum1982; 25: 42–47.
7.
DaoTOhashiKKayanoT: Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol1997; 173: 230–235.
8.
KohnoKKataokaJOhtsukiT: IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol1997; 158: 1541–1550.
KawanakaNYamamuraMAitaT: CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum2002; 46: 2578–2586.
11.
KoizumiHSato-MatsumuraKCNakamuraH: Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes. Arch Dermatol Res2001; 293: 325–333.
12.
NicolettiFCongetIDi MarcoR: Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia2001; 44: 309–311.
13.
ShanNNZhuXJWangQ: High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura. Haematologica2009; 94: 1603–1607.
14.
ShanNNZhuXJPengJ: Interleukin 18 and interleukin 18 binding protein in patients with idiopathic thrombocytopenic purpura. Br J Haematol2009; 144: 755–761.
15.
GracieJAForseyRJChanWL: A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest1999; 104: 1393–1401.
16.
DinarelloCA: Targeting interleukin 18 with interleukin 18 binding protein. Ann Rheum Dis2000; 59: 17–20.
17.
NovickDKimSHFantuzziG: Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response. Immunity1999; 10: 127–136.
18.
MillsJAMichelBABlochDA: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum1990; 33: 1114–1121.
19.
PfafflMWHorganGWDempfleL: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res2002; 30: e36.
20.
NakamotoYAsanoYDohiK: Primary IgA glomerulonephritis and Schönlein-Henoch purpura: clinicopathological and immunohistological characteristics. Q J Med1978; 47: 495–516.
21.
HaTS: The role of tumor necrosis factor-α in Henoch-Schönlein purpura. Pediatr Nephrol2005; 20: 149–153.
22.
OzaltinFBesbasNUckanD: The role of apoptosis in childhood Henoch-Schönlein purpura. Clin Rheumatol2003; 22: 265–267.
23.
YangYHLaiHJHuangCM: Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells. Ann Rheum Dis2004; 63: 1511–1513.
MallatZCorbazAScoazecA: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation2001; 104: 1598–1603.
26.
MühlHPfeilschifterJ: Interleukin-18 bioactivity: A novel target for immunopharmacological anti-inflammatory intervention. Eur J Pharmacol2004; 500: 63–71.
27.
YamakawaJTakahashiTSaegusaS: Effect of the serotonin blocker sarpogrelate on circulating interleukin-18 levels in patients with diabetes and arteriosclerosis obliterans. J Int Med Res2004; 32: 166–169.
28.
TamuraRTakahashiHKXueD: Enhanced effects of combined bu-zhong-yi-qitang (TJ-41) and interleukin-18 on the production of tumour necrosis factor-α and interferon-γ in human peripheral blood mononuclear cells. J Int Med Res2004; 32: 25–32.
29.
ArikiNMorimotoYYagiT: Activated T cells and soluble molecules in the portal venous blood of patients with cholestatic and hepatitis C virus-positive liver cirrhosis. Possible promotion of Fas/FasL-mediated apoptosis in the bile-duct cells and hepatocyte injury. J Int Med Res2003; 31: 170–180.
30.
ZhangDDZhaoJ: Study on the levels of IL-18, VEGF in patients with Henoch-Schönlein purpura. China Modern Doctor2009; 47: 45–48.
31.
AizawaYAkitaKTaniaiM: Cloning and expression of interleukin-18 binding protein. FEBS Lett1999; 445: 338–342.
32.
PaulukatJBosmannMNoldM: Expression and release of IL-18 binding protein in response to IFN-γ. J Immunol2001; 167: 7038–7043.
33.
LuceyDRClericiMShearerGM: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev1996; 9: 532–562.
34.
SmeetsRLvan de LooFAArntzOJ: Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice. Gene Ther2003; 10: 1004–1011.
35.
BandaNKVondracekAKrausD: Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J Immunol2003; 170: 2100–2105.
36.
LudwiczekOKaserANovickD: Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease. Eur Cytokine Netw2005; 16: 27–33.
37.
KimuraTKatoZOhnishiH: Expression, purification and structural analysis of human IL-18 binding protein: A potent therapeutic molecule for allergy. Allergol Int2008; 57: 367–376.
38.
LengJYaoHShenJ: Coexpression of IL-18 binding protein and IL-4 regulates Th1/Th2 cytokine response in murine collagen-induced arthritis. Acta Biochim Biophys Sin (Shanghai)2008; 40: 116–124.
39.
NoldMHauserIAHöflerS: IL-18BPa: Fc cooperates with immunosuppressive drugs in human whole blood. Biochem Pharmacol2003; 66: 505–510.
